U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07328464) titled 'Occupational Exposure to Antineoplastic Drugs Among Physiotherapists in Healthcare Settings' on Dec. 24, 2025.
Brief Summary: Many antineoplastic drugs are considered "hazardous to handle" for healthcare professionals, notably because of their carcinogenic, mutagenic and/or reprotoxic effects. Occupational exposure occurs mainly through the cutaneous route, either by direct contact with the drug and/or indirectly through contact with treated patients and their excreta, or through contact with contaminated surfaces or textiles.
To date, physiotherapists have been little studied in terms of occupational exposure, even though they fre...